Verona Pharma appoints Biresh Roy as chief financial officer

UK respiratory specialist Verona Pharma (AIM: VRP.L) has appointed Biresh Roy as chief financial officer and member of the board of directors, taking over from Richard Bungay.

Mr Roy has experience in financing international merger and acquisition deals, growth and company turnarounds, with particular experience in pharma, biotech and medical device companies. He founded Ebury Capital and Growth Solutions in December 2012, a professional services and investment company, and between 2004 and 2011 was adviser to several venture capital and private equity firms. Mr Roy was chief financial officer to several companies during this time, including biotech and pharma firms Enigma diagnostics, Xytis, Morphochem and Santhera.

Jan-Anders Karlsson, chief executive of Verona, said: “Having successfully raised significant capital earlier this year, we look forward to having Biresh on our team.  His experience will be invaluable as we build the company and seek to develop the full potential of RPL554 in respiratory disease to create significant shareholder value. The board would like to thank Richard for his significant contributions and counsel to Verona Pharma, especially during the recent fundraising and wish him well for the future.”